Maria Jose Baracat's testosterone pellet claims, reviewed

What did @mariajosebaracat actually say?

Honestly, this is a tough one to fact-check at face value. The auto-generated transcript for this video is essentially unusable, a garbled mess that captures none of the Spanish-language content the creator clearly delivered. What we can work with is the caption, which promotes testosterone pellets as offering "constant release, more energy, and better performance" under medical supervision, with "hormonal balance, not excess" as the guiding principle.

That framing, pellets as a steady-release, medically supervised option, is a reasonable characterization of how subcutaneous testosterone pellets are marketed and used in clinical practice. The caption does not make extreme claims. It does not promise a cure, name a dose, or say pellets are superior to other forms. That restraint is worth noting.

Does the science back this up?

Partially, yes. The "constant release" claim has real pharmacokinetic support, but the "more energy and better performance" framing needs unpacking. Those outcomes are real for people with diagnosed hypogonadism, but they are not guaranteed for everyone who gets a pellet inserted.

Testosterone pellets, typically fused crystalline testosterone inserted subcutaneously in the hip or buttock, do produce relatively stable serum testosterone levels over 3 to 6 months. A study by Handelsman and Zajac (2004, Expert Opinion on Pharmacotherapy) confirmed that pellet implants produce sustained physiological testosterone levels with less peak-to-trough variability than injections. That part checks out.

The "more energy" claim is conditionally accurate. Bhasin et al. (2010, New England Journal of Medicine) showed testosterone therapy improved energy and libido in hypogonadal men, but effects in eugonadal individuals, people with normal testosterone levels, are far less consistent. Energy benefits are not a universal outcome of pellet therapy.

What did they get wrong (or right)?

The creator did not get much factually wrong in what we can assess from the caption. The emphasis on medical supervision and hormonal balance rather than excess is genuinely the right framing, and it is refreshing on a platform where testosterone content often skews toward optimization culture and bro-science dosing.

That said, there are important omissions. Pellets are not FDA-approved for any indication. They are compounded products regulated at the state pharmacy level. That is a significant regulatory fact that gets glossed over constantly in wellness content. Pellet dosing is also less adjustable than injections or gels. Once the pellet is inserted, you cannot reduce the dose if levels run high. Side effects from over-implantation, including polycythemia and suppression of natural testosterone production, are real concerns. A study by Pastuszak et al. (2017, Journal of Sexual Medicine) found that pellet therapy had higher rates of complications, including extrusion and infection, compared to other delivery methods, though it also showed high patient satisfaction.

What should you actually know?

Testosterone pellets are a legitimate option within hormone therapy, but they come with tradeoffs that social media content rarely addresses honestly. Here is what matters before you consider them.

First, pellets are compounded, not FDA-approved. That means quality and dosing can vary between compounding pharmacies. This is not a reason to avoid them outright, but it is a reason to ask your prescribing provider which pharmacy they use and whether it is USP-797 compliant.

Second, the "steady release" benefit is real, but so is the inflexibility. If your levels go too high, there is no good way to course-correct quickly. Regular lab monitoring, including serum testosterone, hematocrit, and estradiol, is not optional. It is the minimum standard of care.

Third, testosterone therapy of any kind suppresses endogenous production. That is true for pellets, injections, and gels. Anyone presenting pellets as a "natural" hormone restoration without acknowledging this is leaving out important biology.

Finally, the evidence base for testosterone in women, where pellets are frequently promoted, is thinner than for men. The Endocrine Society does not currently recommend testosterone therapy for women outside of specific clinical trials, though practice is evolving.